HEPATITIS D VIRUS (HDV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

• 收藏
• 分享

专利权人:

ALNYLAM PHARMACEUTICALS; INC.

发明人:

HINKLE, GREGORY,JADHAV, VASANT,MAIER, MARTIN,MANOHARAN, MUTHIAH,MILSTEIN, STUART,SHULGA-MORSKAYA, SVETLANA,RAJEEV, KALLANTHOTTATHIL, G.,SEPP-LORENZINO, LAURA,XU, HUILEI

申请号：

SG11201703569X

公开号：

SG11201703569XA

申请日:

2015.11.10

申请国别(地区):

SG

年份:

2017

代理人:

摘要：

The present invention relates to RNAi agents, e.g., double-stranded RNAi agents, targeting the hepatitis B virus (HBV) genome, and methods of using such RNAi agents to inhibit expression of one or more HBV genes and methods of treating subjects having an HBV infection and/or HBV-associated disorder, e.g., chronic hepatitis B infection.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/